Cargando…

Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?

BACKGROUND: Therapeutic activation of tumor‐infiltrating lymphocytes using monoclonal antibodies targeting PD1 or PD‐L1 (immune checkpoint inhibitors—ICIs) has revolutionized treatment of specific solid tumors in adult cancer patients, and much hope has been placed on a similar effect in relapsed or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valind, Anders, Gisselsson, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714551/ https://www.ncbi.nlm.nih.gov/pubmed/33932141 http://dx.doi.org/10.1002/cnr2.1397

Ejemplares similares

Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
por: Rastegar, Bahar, et al.
Publicado: (2023)

The immune cell atlas of human neuroblastoma
por: Verhoeven, Bronte Manouk, et al.
Publicado: (2022)

Primary renal neuroblastoma mimicking Wilms’ tumor
por: Akçaer, Vedat, et al.
Publicado: (2021)

Synchronous Ipsilateral Wilms’ Tumor and Neuroblastoma in an Infant
por: Sarin, Yogesh Kumar, et al.
Publicado: (2016)

Elevated Tolerance to Aneuploidy in Cancer Cells: Estimating the Fitness Effects of Chromosome Number Alterations by In Silico Modelling of Somatic Genome Evolution
por: Valind, Anders, et al.
Publicado: (2013)

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
por: Valind, Anders, et al.
Publicado: (2023)

Timing of Adjuvant Chemotherapy after Laparotomy for Wilms Tumor and Neuroblastoma
por: Ross, A, et al.
Publicado: (2021)

Autoantibody Signature Differentiates Wilms Tumor Patients from Neuroblastoma Patients
por: Schmitt, Jana, et al.
Publicado: (2011)

DEVOLUTION—A method for phylogenetic reconstruction of aneuploid cancers based on multiregional genotyping data
por: Andersson, Natalie, et al.
Publicado: (2021)

Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST
por: Chattopadhyay, Subhayan, et al.
Publicado: (2021)

Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors
por: Pelosi, Andrea, et al.
Publicado: (2021)

What is the optimal duration of immune checkpoint inhibitors in malignant tumors?
por: Yin, Jiaxin, et al.
Publicado: (2022)

Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known
por: Zheng, Caiyun, et al.
Publicado: (2023)

Anti-tumor effects of rigosertib in high-risk neuroblastoma
por: Radke, Katarzyna, et al.
Publicado: (2021)

Regarding human cytomegalovirus in neuroblastoma
por: Forslund, Ola, et al.
Publicado: (2014)

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer
por: Petersson, Alexandra, et al.
Publicado: (2022)

FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next?
por: Saborowski, Anna, et al.
Publicado: (2020)

Immune checkpoint inhibitor-related pancreatitis: What is known and what is not
por: Jiang, Chunyan, et al.
Publicado: (2023)

Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
por: Tovoli, Francesco, et al.
Publicado: (2020)

Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression
por: Karlsson, Jenny, et al.
Publicado: (2016)

Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour.
por: Rebhandl, W., et al.
Publicado: (1998)

Tumor size and prognosis in patients with Wilms tumor
por: Provenzi, Valentina Oliveira, et al.
Publicado: (2015)

Tumor de Wilms/
por: González Ortíz, María de los Angeles
Publicado: (1994)

Wilms' tumor: An update
por: Tongaonkar, Hemant B., et al.
Publicado: (2007)

Phylogeny of Wilms tumor?
por: Charles, Adrian, et al.
Publicado: (2016)

Wilms' tumor of the ovary
por: Alexander, Vinita M., et al.
Publicado: (2016)

Tumor de Wilms.:
por: González Ortiz, María de los Angeles
Publicado: (1994)

Tumor de Wilm's : (nefroblastoma)
por: Poisot Foglia, Gumaro
Publicado: (1997)

Multiple mechanisms of MYCN dysregulation in Wilms tumour
por: Williams, Richard D., et al.
Publicado: (2015)

Immune-checkpoint inhibitors for glioblastoma: what have we learned?
por: Omuro, Antonio
Publicado: (2022)

Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
por: Lee, Seon-Mi, et al.
Publicado: (2023)

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
por: Astuti, D, et al.
Publicado: (2004)

Neuroblastoma presenting like a Wilms’ tumor with thrombus in inferior vena cava and pulmonary metastases: a case series
por: Gaetan, Genevieve, et al.
Publicado: (2014)

Management and outcomes in massive bilateral Wilms’ tumors
por: Agarwala, Sandeep, et al.
Publicado: (2014)

MiR-21 Expression in Wilms’ Tumor
por: Bazzaz, Navid, et al.
Publicado: (2018)

Outcome of Children with Wilms’ Tumor in Developing Countries
por: Bahoush, Gholamreza, et al.
Publicado: (2020)

Wilms' Tumor in Horseshoe Kidney
por: Luu, Doan Tien, et al.
Publicado: (2021)

Educational Case: Wilms Tumor
por: Huppmann, Alison R.
Publicado: (2018)

Testicular metastasis in Wilms’ tumor
por: Dhal, Shikha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mu0iibl3picv9s1o13i6ib1h8a